A detailed history of Windsor Group LTD transactions in Pfizer Inc stock. As of the latest transaction made, Windsor Group LTD holds 6,542 shares of PFE stock, worth $185,138. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,542
Previous 6,132 6.69%
Holding current value
$185,138
Previous $225,000 3.56%
% of portfolio
0.04%
Previous 0.04%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

BUY
$32.09 - $37.51 $13,156 - $15,379
410 Added 6.69%
6,542 $217,000
Q2 2023

Jul 12, 2023

BUY
$36.12 - $41.79 $13,147 - $15,211
364 Added 6.31%
6,132 $225,000
Q1 2023

Apr 19, 2023

BUY
$39.39 - $51.28 $236 - $307
6 Added 0.1%
5,768 $241,000
Q4 2022

Feb 01, 2023

BUY
$41.75 - $54.5 $2,129 - $2,779
51 Added 0.89%
5,762 $293,000
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $87 - $106
2 Added 0.04%
5,711 $242,000
Q2 2022

Aug 08, 2022

SELL
$46.53 - $55.17 $984,016 - $1.17 Million
-21,148 Reduced 78.74%
5,709 $301,000
Q1 2022

May 04, 2022

SELL
$45.75 - $56.69 $64,507 - $79,932
-1,410 Reduced 4.99%
26,857 $1.48 Million
Q4 2021

Jan 21, 2022

SELL
$41.32 - $61.25 $151,148 - $224,052
-3,658 Reduced 11.46%
28,267 $1.54 Million
Q3 2021

Oct 12, 2021

BUY
$39.25 - $50.42 $430,415 - $552,905
10,966 Added 52.32%
31,925 $1.37 Million
Q2 2021

Jul 26, 2021

SELL
$35.91 - $40.68 $197,038 - $223,211
-5,487 Reduced 20.75%
20,959 $821,000
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $118,856 - $134,045
3,549 Added 15.5%
26,446 $958,000
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $57,200 - $72,735
1,709 Added 8.07%
22,897 $843,000
Q3 2020

Nov 06, 2020

BUY
$31.75 - $37.25 $92,456 - $108,472
2,912 Added 15.93%
21,188 $803,000
Q2 2020

Jul 06, 2020

BUY
$30.12 - $36.54 $4,578 - $5,554
152 Added 0.84%
18,276 $598,000
Q1 2020

Apr 13, 2020

SELL
$27.03 - $38.62 $306,979 - $438,607
-11,357 Reduced 38.52%
18,124 $592,000
Q4 2019

Jan 07, 2020

BUY
$32.92 - $37.36 $211,346 - $239,851
6,420 Added 27.84%
29,481 $1.16 Million
Q3 2019

Oct 21, 2019

SELL
$32.49 - $42.13 $129,212 - $167,551
-3,977 Reduced 14.71%
23,061 $786,000
Q2 2019

Jul 15, 2019

BUY
$36.98 - $41.52 $335,001 - $376,129
9,059 Added 50.39%
27,038 $1.18 Million
Q1 2019

Apr 09, 2019

BUY
$37.5 - $41.2 $24,075 - $26,450
642 Added 3.7%
17,979 $764,000
Q4 2018

Jan 15, 2019

SELL
$38.47 - $43.86 $309,375 - $352,722
-8,042 Reduced 31.69%
17,337 $757,000
Q3 2018

Oct 05, 2018

BUY
$34.47 - $41.81 $276,242 - $335,065
8,014 Added 46.15%
25,379 $1.12 Million
Q2 2018

Jul 31, 2018

BUY
$32.98 - $35.16 $13,818 - $14,732
419 Added 2.47%
17,365 $630,000
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $4,403 - $5,108
-138 Reduced 0.81%
16,946 $601,000
Q4 2017

Mar 01, 2018

BUY
$33.26 - $35.29 $568,213 - $602,894
17,084
17,084 $619,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $159B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Windsor Group LTD Portfolio

Follow Windsor Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Windsor Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Windsor Group LTD with notifications on news.